Microsatellite Instability in Endometrial Carcinoma.

  • Sharanjit Singh Toor Dept of Pathology, Armed Forces Medical College
  • Prateek Kinra Dept of Pathology, Armed Forces Medical College
  • Aman Kumar Dept of Pathology, Armed Forces Medical College
  • Onkar Singh Hothi Dept of Pathology, Armed Forces Medical College.
Keywords: Endometrial carcinoma, microsatellite instability, lynch syndrome, colorectal carcinoma, carcinogenesis


Background: Endometrial carcinoma is the commonest gynaecological malignancy in the western countries with a standardised incidence of 8 per 100000 women. In India and Southeast Asia, the incidence of endometrial carcinoma is low but it is increasing due to increasing prevalence of obesity, diabetes, early menarche, late menopause, late marriage and declining birth rate. The study aimed to identify the role of microsatellite instability in endometrial carcinoma. Although MSI has been studied extensively in colorectal carcinoma there have been very few studies in southeast asian region regarding association of MSI and prognosis in endometrial carcinoma. To the best of our knowledge this is first study in India. Method: A Descriptive study in which 40 patients of endometrial carcinoma were studied. MSI was detected using immunohistochemistry (MSH-1, PMS-2, MSH-2, MSH-6). Statistical Analysis was done using SPSS software and fisher exact test was used to calculate p value. p value less than.05% was considered significant. Results: Overall prevalence of microsatellite instability was 40%. Microsatellite instability was associated with higher tumor grade, myometrial invasion>50% and presented in initial stages compared to microsatellite stable tumors. Conclusion: Our study showed statistically significant association between microsatellite instability and Figo staging, tumor grade and myometrial invasion.


1. Kunitomi H, Banno K, Yanokura M, Takeda T, Iijima M, Nakamura K, Iida M, Adachi M, Watanabe K, Matoba Y, Kobayashi Y, Tominaga E, Aoki D. New use of microsatellite instability analysis in endometrial cancer. Oncol Lett. 2017;14(3):3297‐3301.
2. Jernvall P, Makinen MJ, Karttunen TJ, Makela J, Vihko P. Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer 1999; 35: 197– 201.
3. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000; 342: 69– 77.
4. Caduff RF, Johnston CM, Svoboda‐Newman SM, Poy EL, Merajver SD, Frank TS. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am J Pathol 1996; 148: 1671– 8.
5. American Joint Committee on Cancer. Cervix Uteri. In: AJCC cancer staging manual. 8th ed. New York, NY: Springer, 2017; 649–659.
6. Salvesen HB, Haldorsen IS, Trovik J. Markers for individualised therapy in endometrial carcinoma. Lancet Oncol. 2012;13:e353–e361.
7. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159– 70

8. Meyer LA, Broaddus RR, Lu KH. Endometrial Cancer and Lynch Syndrome: Clinical and Pathologic Considerations. Cancer Control. 2009; 16: 14-22.
9. Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, et al. Association of Tumor Morphology With Mismatch-Repair Protein Status in Older Endometrial Cancer Patients: Implications for Universal Versus Selective Screening Strategies for Lynch Syndrome. Am J Surg Pathol .2014;38: 793-800.
10. Mills AM, Liou S, Ford JM, Berek JS, Pai RK, et al. Lynch Syndrome Screening Should be Considered for all Patients With Newly Diagnosed Endometrial Cancer. Am J Surg Pathol. 2014; 38: 1501-1509.
11. Broaddus RR, Lynch HT, Chen Lm, Daniels MS, Conrad P, et al. Pathologic Features of Endometrial Carcinoma Associated with HNPCC. Cancer. 2006;106: 87-94.
12. Hashmi AA, Mudassir G, Hashmi RN, et al. Microsatellite Instability in Endometrial Carcinoma by Immunohistochemistry, Association with Clinical and Histopathologic Parameters. Asian Pac J Cancer Prev. 2019;20(9):2601‐2606.
13. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138:2073–87 e3.
14. Hong SP, Min BS, Kim TI, et al. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer. Eur J Cancer. 2012;48(8):1235‐1243
15. Hirasawa A, Aoki D, Inoue J, Imoto I, Susumu N, Sugano K, et al. Unfavorable prognostic factors associated with high frequency of microsatellite instability and comparative genomic hybridization analysis in endometrial cancer. Clin Cancer Res 2003;9:5675–82.
16. H.J. An, K.I. Kim, J.Y. Kim, J.Y. Shim, H. Kang, T.H. Kim, et al.Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators. Am J SurgPathol, 31 (2007), pp. 846-853
17. Vilar E, Gruber SB. Microsatellite Instability in Colorectal Cancer-the Stable Evidence. Nat Rev Clin Oncol. 2010; 7: 153-162.
18. Buchanan DD, Tan YY, Walsh MD. Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 Years Optimizes Triage for Population-Level Germline Mismatch Repair Gene Mutation Testing. J Clin Oncol. 2014; 32: 90-100.
19. Goodfellow PJ, Billingsley CC, Lankes HA, Ali S, Cohn DE, et al. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. J Clin Oncol . 2015; 33: 4301-4308.
20. Patil PA . Microsatellite Instability Testing In Endometrial Cancer - A Short Review. J Oncol Res Treat. 2018; 3: 126.
21. Howitt BE, Shukla SA, Sholl LM, et al. Association of polymerase e-mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1. JAMA Oncol. 2015;1:1319–23.
Original Article